Recommendations Guide Oral Immunotherapy for Food Allergies

  • 📰 Medscape
  • ⏱ Reading Time:
  • 64 sec. here
  • 29 min. at publisher
  • 📊 Quality Score:
  • News: 120%
  • Publisher: 55%

Food Allergy News

Food Hypersensitivity,Biologic Therapy,Biologics

A consensus document emphasizes the control of comorbidities, contraindications to oral immunotherapy, and the importance of informed consent.

. The recommendations aim to increase the treatment's safety and decrease the potential for allergic reactions., the management of social and behavioral factors such as parental disagreement, and the benefits of OIT. The authors also present evidence-based guidance on contraindications, risk mitigation, and discontinuation of OIT. Finally, they stress the importance of informed consent.

A 36-member international panel of pediatric allergists, adult allergists, and immunologists developed a consensus document on patient preparation and consent for OIT. They used a Delphi methodology to reach consensus on statements and themes. More than 300 statements were initially proposed from consent forms, processes, and standard operating procedures that are already in use.

The panel also reached consensus on OIT alternatives including continued food avoidance . There was also unanimous agreement on the ability to discuss OIT discontinuation any time., Michael Pistiner, MD, director of food allergy advocacy, education, and prevention at Massachusetts General Hospital for Children in Boston, said that it will support parents and families in informed OIT initiation.

Pistiner described the methodology as sound and noted that panelists covered all the relevant topics that affect the safe initiation of OIT."They hit upon all the things that I would have wanted to see them hit upon," he said."I am definitely going to be using the talking points that they have developed. I think that this publication is helpful because it helps a team standardize and streamline those initial conversations that can take up to an hour.

Food Hypersensitivity Biologic Therapy Biologics Asthma Asthmatic Immunotherapy Canada Severe Asthma Uncontrolled Asthma Allergy Children Child Childhood Pediatrics Kids Anaplastic Lymphoma Kinase ALK ALK Tyrosine Kinase Receptor CD246 Cluster Of Differentiation 246 Patient Safety Agriculture/Farming Allergens Board Certification Boards Board Recertification

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Remarkable Patients Inspired Father of Cancer ImmunotherapyThe father of cancer immunotherapy, Steven A. Rosenberg, reflects on the patients who inspired his groundbreaking research.
Source: Medscape - 🏆 386. / 55 Read more »

Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early TrialA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Source: MedicineNet - 🏆 575. / 51 Read more »

ImPrint Biomarker Identifies Breast Cancer Patients Likely to Respond to ImmunotherapyUsing ImPrint, an immune-related biomarker, clinicians can identify patients with breast cancer who are likely to respond to neoadjuvant immunotherapy, according to data from the Patient selection based on ImPrint class can result in high response rates and spare nonresponders the toxicities of immunotherapy.
Source: Medscape - 🏆 386. / 55 Read more »

Subcutaneous Immunotherapy: Better Life for Patients With CancerAdministering immunotherapy via subcutaneous infections could save clinicians time and money and patients may prefer it.
Source: Medscape - 🏆 386. / 55 Read more »

Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapyPurdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.
Source: physorg_com - 🏆 388. / 55 Read more »

New immunotherapy could make blood more 'youthful,' mouse study hintsEmily is a health news writer based in London, United Kingdom. She holds a bachelor's degree in biology from Durham University and a master's degree in clinical and therapeutic neuroscience from Oxford University. She has worked in science communication, medical writing and as a local news reporter while undertaking journalism training.
Source: LiveScience - 🏆 538. / 51 Read more »